Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - ACCOUNTS PAYABLE
Accounts Payable PTGX - Protagonist Therapeutics, Inc.
772 K
LAST VALUE
-30.54%
2 YEAR CAGR
-32.98%
5 YEAR CAGR
0.00%
10 YEAR CAGR